Correlate the following nuanced infectious disease presentations and resistance profiles with their optimal pharmacologic management.
- Five days following a decompressive craniectomy for severe traumatic brain injury, a patient in the surgical intensive care unit exhibits a new fever and nuchal rigidity. Analysis of the cerebrospinal fluid demonstrates significant neutrophilic pleocytosis with a negative Gram stain.Intravenous vancomycin plus intravenous cefepime
- During a routine pulmonology follow-up, a young adult with cystic fibrosis reports a steady decline in respiratory baseline parameters over the last month. Previous sputum analyses have consistently isolated Burkholderia cepacia complex.Oral trimethoprim-sulfamethoxazole
- A patient undergoing induction chemotherapy for leukemia remains persistently hypotensive despite 48 hours of empiric cefepime therapy for febrile neutropenia. The microbiology laboratory notifies the team that admission blood cultures are now growing a beta-lactamase–producing Bacteroides fragilis.Supplement the current regimen with intravenous metronidazole
- Twenty-four hours after sustaining a minor laceration while cleaning freshly caught saltwater fish, a patient with advanced hepatic cirrhosis presents with rapidly expanding, hemorrhagic cutaneous bullae on the affected extremity.Initiate dual therapy with intravenous ceftriaxone and intravenous doxycycline
- An obstetric patient at 16 weeks of gestation requires hospital admission for acute pyelonephritis. Her outpatient urine cultures are finalized, revealing an Escherichia coli strain that produces an extended-spectrum beta-lactamase (ESBL).Initiate intravenous ertapenem
Answer
The correct matches align specific pathogen vulnerabilities and resistances with targeted therapies: Post-neurosurgical meningitis requires MRSA and Pseudomonas coverage (vancomycin + cefepime); B. cepacia intrinsically requires TMP-SMX; Cefepime lacks anaerobic coverage for Bacteroides, necessitating metronidazole; V. vulnificus in cirrhosis demands ceftriaxone + doxycycline; and ESBL pyelonephritis in pregnancy is safely managed with ertapenem.
Each pairing tests a critical exception or specific rule in antimicrobial stewardship. Healthcare-associated central nervous system infections demand specific antipseudomonal and MRSA coverage. Pathogens like Burkholderia cepacia and ESBL-producing E. coli harbor distinct resistance profiles that render standard empiric therapies ineffective, necessitating TMP-SMX and carbapenems, respectively. Furthermore, understanding the precise spectrum of broad-spectrum agents (such as cefepime's lack of anaerobic efficacy) and the synergistic regimens required for unique environmental exposures (like Vibrio vulnificus) is essential for preventing adverse clinical outcomes.
Step-by-Step Solution
Key Concept
Antimicrobial stewardship and targeted drug selection based on complex host factors, environmental exposure history, and intrinsic or acquired pathogen resistance profiles.